Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) SHH

13.66

-0.19(-1.37%)

Updated at June 03 11:28AM

Currency In CNY

Valuation

Market Cap3.15B
Enterprise Value3.11B
P/E Ratio47.95
PEG Ratio-4,318.66T
Price/Sales Ratio3.11
Price/Book Ratio1.61
Enterprise/Revenue2.82
Enterprise/EBITDA26.1

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.08

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue844.54M
Revenue/Share4.41
Gross Profit220.87M
EBITDA158.44M
Net Income62.16M
Diluted EPS0.35

Balance Sheet

Total Cash603.14M
Total Cash/Share3.2
Total Debt330.71M
Total Debt/Equity0.21
Current Ratio4.69
Book Value Per Share8.66

Price History

52-Week Change-19.08
52-Week High22
52-Week Low13.61
Moving Average 50 Days16.01
Moving Average 200 Days17.85

Statistics

Average Volume3.52M
Shares Outstanding189.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.11
Last Split Factor7:5
Last Split DateJune 08, 2020